Anonymous (2002) Engineering high
avidity CTLA4lg for therapy of rheumatic diseases. Expert Opinion on
Therapeutic Patients 12 (9): 1455-7.
We’re
unable to obtain via usual ILL sources.
Thanks
in advance for any assistance,
Happy
New Year,
Karin
Dearness
National
Institute for Clinical Excellence
71
High Holborn